BarbriSFCourseDetails

Course Details

This CLE webinar will discuss the role of corporate representatives at trial and strategies for counsel either representing or opposing the company. The panel will discuss selecting "appearance" only representatives and those who have also been deposed under Federal Rule 30(b)(6). The panel will review factors to consider when deciding whether to have an "appearance" representative or not, how that designation limits opposing counsel's options on cross-examination, and what risks the appearance representative faces. The program will also review Rule 32 and other applicable procedural and evidentiary rules.

Faculty

Description

Parties that are entities typically have a representative present at trial: (1) to put a human face on the entity; (2) to assist counsel; and (3) to hear the testimony of the opposing witnesses since this person is exempt from the rule of sequestration.

This "appearance" corporate representative often has no or marginal knowledge and/or involvement in the events being litigated. Other times, the appearance representative may also have been deposed as a Rule 30(b)(6) representative.

When an appearance representative is called to testify at trial, it is unclear whether the witness is testifying only from personal knowledge as an appearance representative or as a 30(b)(6) representative. The answer drives the scope of examination at trial and whether prior testimony will be admissible. Opposing counsel may seek to call the representative as an adverse witness to force admissions that the witness knows nothing about critical facts.

Both sides have strategic decisions to make regarding how to treat and deal with a corporate representative at trial. Trial counsel should take steps to prepare for and deal with multiple scenarios based on what opposing counsel does. To assess these strategies, counsel should be familiar with, among other rules, Federal Rule 32.

Listen as this panel discusses strategies for dealing with the differences between the "appearance" representative and the corporate Rule 30(b)(6) representative.

Outline

  1. Applicable Federal Rules of Procedure and Evidence
    1. Scope of questioning in discovery vs. at trial
    2. Use of prior testimony
    3. Rule of sequestration
  2. Role of appearance representatives at trial
    1. Generally
    2. When appearance representatives were not 30(b)(6) designees
    3. When appearance representatives were 30(b)(6) designees
    4. Limits on cross-examination
    5. Perils of calling adverse witnesses on direct
  3. Strategies for the company
  4. Strategies for opposing counsel

Benefits

The panel will discuss these and other key issues:

  • Should a corporate representative--either in an appearance or a 30(b)(6) capacity--be treated as a party versus a non-party witness to the litigation?
  • Can a person designated as the corporate representative for appearance purposes only be protected from being called by the opposing side as an adverse witness in his or her capacity as a corporate representative?
  • Is listing "a corporate representative of the defendant," or adopting the other party's witness list, sufficient to include the corporate representative designated for purposes of appearance at trial?
  • What application does Federal Rule 32 have?